SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 320.20 |
Enterprise Value ($M) | 241.46 |
Book Value ($M) | 78.88 |
Book Value / Share | 2.81 |
Price / Book | 4.06 |
NCAV ($M) | 78.62 |
NCAV / Share | 2.80 |
Price / NCAV | 4.07 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.45 |
Return on Assets (ROA) | -8.17 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.99 |
Current Ratio | 5.99 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 94.57 |
Assets | 94.84 |
Liabilities | 15.95 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -13.52 |
Net Income | -37.64 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -13.95 |
Cash from Investing | 6.60 |
Cash from Financing | 16.44 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | 5AM Partners VII, LLC | 40.00 | 4.00 | |
13G | Sphera Funds Management Ltd. | 5.39 | ||
13G | Altium Capital Management LP | 5.40 | 0.00 | |
13G | Versant Venture Capital III, L.P. | 19.70 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
80,226 | 147,498 | 54.39 | |
11,930 | 8,565 | 139.29 | |
12,301 | 11,251 | 109.33 | |
16,177 | 10,759 | 150.36 | |
(click for more detail) |
Similar Companies | |
---|---|
SCYX – SCYNEXIS, Inc. | SGMT – Sagimet Biosciences Inc. |
SIGA – SIGA Technologies, Inc. | SLGL – Sol-Gel Technologies Ltd. |
SMMT – Summit Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io